Source: PharmaLive

Acetylon Pharmaceuticals: Celgene Acquires Acetylon, Will Spin Out Startup

Celgene will acquire Acetylon Pharmaceuticals and spin off some of its pipeline into a new company, Regenacy Pharmaceuticals.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Walter C. Ogier's photo - President & CEO of Acetylon Pharmaceuticals

President & CEO

Walter C. Ogier

CEO Approval Rating

70/100

Read more